Accuray Incorporated and RaySearch Laboratories have expanded their collaboration to accelerate the adoption of online adaptive radiation therapy, combining Accuray's radiation platforms with RaySearch's treatment planning software. The initial focus is on Accuray's Radixact system, with plans to extend to the CyberKnife platform. This technology allows treatment plans to be adjusted in real-time based on patient anatomy, aiming to provide more personalized and efficient cancer treatments. Accuray will purchase $8 million in RayStation licenses to support commercialization, and both companies will jointly market and support the solutions.
Enova reported strong Q3 results with 33% adjusted EPS growth and 26% revenue growth, supported by a focus on business loans and a lower net charge-off ratio. Despite the failed acquisition of Grasshopper Bank, management plans to accelerate share bu...
A Bitcoin transaction on October 17 placed a 100-byte plaintext message in block 971,914 using an OP_RETURN output, which allows data to be recorded but not spent. This message, paying a fee of 253 satoshis, included text about quartz clocks and the ...
U.S. spot Bitcoin ETFs experienced a sharp reversal with $524.8 million in inflows on October 21 followed by $635.6 million in outflows on October 22 and another $137.9 million withdrawn on October 23. Despite these withdrawals, the net inflow for th...
Ethereum prices fell to the $2,350-$2,380 range following large sell-offs by BitMEX co-founder Arthur Hayes, who liquidated Ethereum and DeFi assets ahead of the Federal Reserve's critical policy meeting. This move reflects institutional caution amid...
Stellar Lumens (XLM) was trading at $0.1679 on October 25, slightly below the forecasted target of $0.174 set for October 27. This represents a 1.66% increase expected by the forecast, but the current price is down 1.08% over the past 24 hours. Techn...
